Leukemia Research
Volume 33, Issue 11 , Pages 1475-1480, November 2009

Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma

  • Sherif S. Farag

      Affiliations

    • Departments of Internal Medicine and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States
    • Corresponding Author InformationCorresponding author at: Division of Hematology and Oncology, Department of Internal Medicine, Indiana University School of Medicine, 635 Barnhill Drive, Room 224G, Indianapolis, IN 46202, United States. Tel.: +1 317 278 0460; fax: +1 317 278 2262.
  • ,
  • Shuhong Zhang

      Affiliations

    • Departments of Internal Medicine and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States
  • ,
  • Buffy S. Jansak

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States
  • ,
  • Xiaojing Wang

      Affiliations

    • Departments of Internal Medicine and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States
  • ,
  • Eric Kraut

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States
  • ,
  • Kenneth Chan

      Affiliations

    • College of Pharmacy, The Ohio State University, Columbus, OH, United States
  • ,
  • Janet E. Dancey

      Affiliations

    • National Cancer Institute, Bethesda, MD, United States
  • ,
  • Michael R. Grever

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States

Received 17 November 2008; received in revised form 28 January 2009; accepted 30 January 2009. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(09)00060-5

doi:10.1016/j.leukres.2009.01.039

Leukemia Research
Volume 33, Issue 11 , Pages 1475-1480, November 2009